Replies to post #204285 on Bioelectronics Corp (BIEL)

[Patient Invester]

I honestly can’t see Biel canceling shares.

And obviously there’s way too many shares out there for such a small company.

No institutional investor is gonna take this company seriously with the current share structure as it is.

Unfortunately the positive Longs are really living in a fantasy world right now. The pps will probably be like this or not above a penny even at the end 2022.

Reality kind of sinks in when the company moves slower than a snail.

I mean come on a new CEO can’t even be named yet by now...really?!

Does this company even want to survive ? Or even grow?

Biel must think they have all the time in the world.

Guess what the opioid crisis will be over when other medical tech companies offer their product solutions, while Biel was too busy still trying to find a CEO by doing everything by the book which can take a very very long time not to mention costly by legal counsel at this point of time.

At this point of time Biel should be sold to a entity that can execute in a more successful and timely manner.

In the business world you gotta be fast.